A rapid, one step assay for simultaneous detection of <i>FLT3</i>/ITD and <i>NPM1</i> mutations in AML with normal cytogenetics

Qin Huang(People's Hospital of Xinjiang Uygur Autonomous Region), Lawrence M. Weiss(NeoGenomics (United States)), Anthony S. Stein(University of Hohenheim), Karl Gaal(City Of Hope National Medical Center), Wengang Chen(City Of Hope National Medical Center), Marilyn L. Slovak(City Of Hope National Medical Center)
British Journal of Haematology
May 9, 2008
10.1111/j.1365-2141.2008.07205.x
Cited by 51

Related Papers

Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/Eastern Cooperative Oncology Group study
|Blood|2000|1.6k
Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages
|Blood|2016|1.6k
Enasidenib in mutant IDH2 relapsed or refractory acute myeloid leukemia
|Blood|2017|1.5k
Durable Remissions with Ivosidenib in <i>IDH1</i> -Mutated Relapsed or Refractory AML
|New England Journal of Medicine|2018|1.4k
Age and acute myeloid leukemia
|Blood|2006|1.4k